Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Non-invasive screening for sub-clinical antibody-mediated rejection as a new tool for indication of kidney allograft biopsy.

Kozakowski N.

EBioMedicine. 2019 Aug;46:13-14. doi: 10.1016/j.ebiom.2019.07.033. Epub 2019 Jul 25. No abstract available.

2.

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection.

Mező B, Heilos A, Böhmig GA, Eskandary F, Wahrmann M, Bond G, Kozakowski N, Halloran PF, Rusai K, Prohászka Z.

Transplant Direct. 2019 Jun 27;5(7):e470. doi: 10.1097/TXD.0000000000000915. eCollection 2019 Jul.

3.

An integrative approach for the assessment of peritubular capillaritis extent and score in low-grade microvascular inflammation-associations with transplant glomerulopathy and graft loss.

Kozakowski N, Herkner H, Eskandary F, Eder M, Winnicki W, Kläger J, Bond G, Kikic Ž.

Nephrol Dial Transplant. 2019 Jan 1;34(1):166-174. doi: 10.1093/ndt/gfy192.

PMID:
30053273
4.

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.

Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Sep;18(9):2261-2273. doi: 10.1111/ajt.14710. Epub 2018 Mar 30.

5.

Lymphotoxin expression in human and murine renal allografts.

Seeger H, Lindenmeyer MT, Cohen CD, Jaeckel C, Nelson PJ, Chen J, Edenhofer I, Kozakowski N, Regele H, Boehmig G, Brandt S, Wuethrich RP, Heikenwalder M, Fehr T, Segerer S.

PLoS One. 2018 Jan 4;13(1):e0189396. doi: 10.1371/journal.pone.0189396. eCollection 2018.

6.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA.

J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.

7.

Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.

Eskandary F, Jilma B, Mühlbacher J, Wahrmann M, Regele H, Kozakowski N, Firbas C, Panicker S, Parry GC, Gilbert JC, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Apr;18(4):916-926. doi: 10.1111/ajt.14528. Epub 2017 Oct 31.

8.

Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment.

Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaider A, Kozakowski N, Weninger WJ, Nanobachvili J, Wojta J, Huk I, Demyanets S, Neumayer C.

Cardiovasc Diabetol. 2017 Aug 8;16(1):98. doi: 10.1186/s12933-017-0579-6.

9.

MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.

Leiss H, Salzberger W, Jacobs B, Gessl I, Kozakowski N, Blüml S, Puchner A, Kiss A, Podesser BK, Smolen JS, Stummvoll GH.

PLoS One. 2017 Jul 18;12(7):e0181015. doi: 10.1371/journal.pone.0181015. eCollection 2017.

10.

NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis.

Eilenberg W, Stojkovic S, Kaider A, Kozakowski N, Domenig CM, Burghuber C, Nanobachvili J, Huber K, Klinger M, Neumayer C, Huk I, Wojta J, Demyanets S.

Clin Chem Lab Med. 2017 Nov 27;56(1):147-156. doi: 10.1515/cclm-2017-0156.

PMID:
28672747
11.

The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.

Bojic M, Kozakowski N, Bécède M, Kerschbaumer A, Bobacz K.

Kidney Int. 2017 Jul;92(1):271-272. doi: 10.1016/j.kint.2016.12.025. No abstract available.

PMID:
28647000
12.

Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft Injury.

Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž.

Transplantation. 2017 May;101(5):e178-e187. doi: 10.1097/TP.0000000000001707.

PMID:
28252564
13.

Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.

Schiemann M, Puchhammer-Stöckl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, Kozakowski N, Görzer I, Kikić Ž, Herkner H, Böhmig GA, Bond G.

Transplantation. 2017 Feb;101(2):360-367. doi: 10.1097/TP.0000000000001455.

14.

Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.

Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.

Nephrol Dial Transplant. 2016 Aug;31(8):1342-51. doi: 10.1093/ndt/gfw027. Epub 2016 Mar 24.

PMID:
27190362
15.

Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor.

Schwarz C, Lawitschka A, Böhmig GA, Dauber EM, Greinix H, Kozakowski N, Mühlbacher F, Berlakovich GA, Wekerle T.

Transplantation. 2016 Oct;100(10):2219-21. doi: 10.1097/TP.0000000000001213.

PMID:
27136263
16.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.

Transplantation. 2017 Mar;101(3):631-641. doi: 10.1097/TP.0000000000001195.

PMID:
27120452
17.

The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury.

Leone DA, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler AG, Haitel A, Rees AJ, Kain R.

PLoS One. 2016 Mar 21;11(3):e0151674. doi: 10.1371/journal.pone.0151674. eCollection 2016.

18.

Tacrolimus, Mycophenolate Mofetil, and Low-Dose Steroids With or Without Interleukin-2 Receptor Antibody Induction Therapy: A Retrospective Cohort Analysis.

Schwarz C, Böhmig G, Steininger R, Unger L, Kristo I, Kozakowski N, Berlakovich GA, Soliman T, Mühlbacher F.

Transplant Proc. 2015 Oct;47(8):2446-9. doi: 10.1016/j.transproceed.2015.08.003.

PMID:
26518948
19.

The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.

Seleznik G, Seeger H, Bauer J, Fu K, Czerkowicz J, Papandile A, Poreci U, Rabah D, Ranger A, Cohen CD, Lindenmeyer M, Chen J, Edenhofer I, Anders HJ, Lech M, Wüthrich RP, Ruddle NH, Moeller MJ, Kozakowski N, Regele H, Browning JL, Heikenwalder M, Segerer S.

Kidney Int. 2016 Jan;89(1):113-26. doi: 10.1038/ki.2015.280. Epub 2016 Jan 4.

PMID:
26398497
20.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.

Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43. doi: 10.2215/CJN.09901014. Epub 2015 Jun 12.

21.

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.

Kozakowski N, Herkner H, Böhmig GA, Regele H, Kornauth C, Bond G, Kikić Ž.

Kidney Int. 2015 Aug;88(2):332-40. doi: 10.1038/ki.2015.64. Epub 2015 Mar 4.

22.

Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.

Poeppl W, Lingscheid T, Bernitzky D, Schwarze UY, Donath O, Perkmann T, Kozakowski N, Plasenzotti R, Reznicek G, Burgmann H.

Antimicrob Agents Chemother. 2014 Sep;58(9):5111-6. doi: 10.1128/AAC.02720-13. Epub 2014 Jun 16.

23.

Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial.

Eskandary F, Bond G, Regele H, Kozakowski N, Kikić Z, Wahrmann M, Haslacher H, Oberbauer R, Ramassar V, Halloran P, Böhmig GA.

Clin Transpl. 2014:189-95.

PMID:
26281144
24.

Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts.

Kikić Z, Kozakowski N, Regele H, Priessner K, Nordmeyer V, Marinova L, Zlabinger GJ, Wahrmann M, Bartel G, Böhmig GA.

Transpl Int. 2014 Mar;27(3):312-21. doi: 10.1111/tri.12254. Epub 2014 Jan 16.

25.

Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment.

Kozakowski N, Hartmann C, Klingler HC, Susani M, Mazal PR, Scharrer A, Haitel A.

Target Oncol. 2014 Dec;9(4):359-66. doi: 10.1007/s11523-013-0298-1. Epub 2013 Nov 17.

PMID:
24243494
26.

Pretransplant risk stratification for early survival of renal allograft recipients.

Kikić Z, Herkner H, Sengölge G, Kozakowski N, Bartel G, Plischke M.

Eur J Clin Invest. 2014 Feb;44(2):168-75. doi: 10.1111/eci.12203. Epub 2013 Dec 9.

PMID:
24224947
27.

Renal elimination of sclerostin increases with declining kidney function.

Cejka D, Marculescu R, Kozakowski N, Plischke M, Reiter T, Gessl A, Haas M.

J Clin Endocrinol Metab. 2014 Jan;99(1):248-55. doi: 10.1210/jc.2013-2786. Epub 2013 Dec 20.

PMID:
24187403
28.

The cutting (w)edge--comparative evaluation of renal baseline biopsies obtained by two different methods.

Bago-Horvath Z, Kozakowski N, Soleiman A, Bodingbauer M, Mühlbacher F, Regele H.

Nephrol Dial Transplant. 2012 Aug;27(8):3241-8. doi: 10.1093/ndt/gfs066. Epub 2012 Apr 6.

PMID:
22492825
29.

Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.

Poeppl W, Tobudic S, Lingscheid T, Plasenzotti R, Kozakowski N, Lagler H, Georgopoulos A, Burgmann H.

Antimicrob Agents Chemother. 2011 Nov;55(11):4999-5003. doi: 10.1128/AAC.00584-11. Epub 2011 Aug 22.

30.

Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model.

Birbach A, Eisenbarth D, Kozakowski N, Ladenhauf E, Schmidt-Supprian M, Schmid JA.

Neoplasia. 2011 Aug;13(8):692-703.

31.

Manifestation of an ameloblastic carcinoma ten years after follicular cyst enucleation in the mandibular ramus.

Pirklbauer K, Kozakowski N, Russmueller G, Ewers R, Klug C.

J Craniomaxillofac Surg. 2012 Jun;40(4):362-5. doi: 10.1016/j.jcms.2011.05.016. Epub 2011 Jul 7.

PMID:
21741264
32.

Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.

Poeppl W, Tobudic S, Lingscheid T, Plasenzotti R, Kozakowski N, Georgopoulos A, Burgmann H.

Antimicrob Agents Chemother. 2011 Feb;55(2):931-3. doi: 10.1128/AAC.00881-10. Epub 2010 Nov 22.

33.

Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function.

Kozakowski N, Regele H.

Transpl Int. 2009 Oct;22(10):945-53. doi: 10.1111/j.1432-2277.2009.00885.x. Epub 2009 Apr 28. Review.

34.

Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome.

Kozakowski N, Böhmig GA, Exner M, Soleiman A, Huttary N, Nagy-Bojarszky K, Ecker RC, Kikić Z, Regele H.

Nephrol Dial Transplant. 2009 Jun;24(6):1979-86. doi: 10.1093/ndt/gfp045. Epub 2009 Feb 17.

35.

BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma.

Kozakowski N, Soleiman A, Pammer J.

Pathol Oncol Res. 2008 Mar;14(1):9-13. doi: 10.1007/s12253-008-9006-3. Epub 2008 Mar 15.

PMID:
18347933

Supplemental Content

Loading ...
Support Center